A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility

A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility

Salvatore Gizzo,1 Juan A Garcia-Velasco,2 Franca Heiman,3 Claudio Ripellino,3 Klaus Bühler4 1Department of Woman and Child Health, University of Padua, Padua, Italy; 2Department of Obstetrics and Gynecology, Rey Juan Carlos University Madrid, Madrid, Spain; 3IMS Health Information Solution...

Full description

Bibliographic Details
Main Authors:	Gizzo S, Garcia-Velasco JA, Heiman F, Ripellino C, Bühler K
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-12-01
Series:	International Journal of Women's Health
Subjects:	FSH follitropin alfa biosimilar infertility.
Online Access:	https://www.dovepress.com/a-cost-effectiveness-evaluation-comparing-originator-follitropin-alfa--peer-reviewed-article-IJWH

Similar Items

Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis
by: Su Jen Chua, et al.
Published: (2021-04-01)

Major results of a phase III comparative multicenter study on the follitropin alfa biosimilar (Primapur®) and the original follitropin alfa (Gonal-f®)
by: Z. B. Barakhoeva, et al.
Published: (2018-11-01)

An observational study «FOLLITROPIN» comparing the efficacy of follitropin alpha biosimilar: the real-world data
by: D. P. Kamilova, et al.
Published: (2021-03-01)

THE NOVEL BIOSIMILAR OF FOLLITROPIN ALPHA TO BE MANUFACTURED IN RUSSIA STARTING FROM 2017
by: I. I. Vorobiev, et al.
Published: (2017-12-01)

A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in Germany
by: Xue W, et al.
Published: (2019-05-01)

Glycosylation Pattern and in vitro Bioactivity of Reference Follitropin alfa and Biosimilars
by: Laura Riccetti, et al.
Published: (2019-07-01)

Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies: A Multinational Comparative, Prospective Cohort Study
by: Sigal Kaplan, et al.
Published: (2021-03-01)

Effectiveness and safety of follitropin alfa (Ovaleap®) for ovarian stimulation using a GnRH antagonist protocol in real-world clinical practice: a multicenter, prospective, open, non-interventional assisted reproductive technology study
by: Peter Sydow, et al.
Published: (2020-05-01)

Corifollitropin alfa versus follitropin beta: an economic analysis alongside a randomized controlled trial in women undergoing IVF/ICSI
by: Le Dang Khoa, et al.
Published: (2020-06-01)

FSH for the Treatment of Male Infertility
by: Livio Casarini, et al.
Published: (2020-03-01)

Ovulation induction with minimal dose of follitropin alfa: a case series study
by: Menabrito Marco, et al.
Published: (2011-10-01)

The continuum of ovarian response leading to BIRTH, a real world study of ART in Spain
by: Marcos Ferrando, et al.
Published: (2020-07-01)

Use of Biosimilar Follicle-Stimulating Hormone in Asthenozoospermic Infertile Patients: A Multicentric Study
by: Maurizio De Rocco Ponce, et al.
Published: (2020-05-01)

The continuum of ovarian response leading to birth, a real world study of ART in Spain
by: M. Ferrando, et al.
Published: (2021-03-01)

Low risk of OHSS with follitropin delta use in women with different polycystic ovary syndrome phenotypes: a retrospective case series
by: Stephanie Yacoub, et al.
Published: (2021-02-01)

In vitro fertilization cycles stimulated with follitropin delta result in similar embryo development and quality when compared with cycles stimulated with follitropin alfa or follitropin beta
by: Olga Haakman, M.D., et al.
Published: (2021-03-01)

The effect of recombinant follicle-stimulating hormone on semen parameters after varicocelectomy in infertile men
by: Atoosa Bagheri Behzad, et al.
Published: (2015-12-01)

A PEN INJECTOR FOR SELF-ADMINISTRATION OF FOLLITROPIN ALPHA SOLUTION WITH A MINIMAL DOSE INCREMENT OF 5 IU
by: A. B. Podkorytov, et al.
Published: (2018-02-01)

Comparison of Pharmacokinetic, Pharmacodynamic and Tolerability Profiles of CKD-11101, Darbepoetin Alfa (NESP®) Biosimilar, to Those of NESP® After a Single Subcutaneous or Intravenous Administration to Healthy Subjects
by: Jeon I, et al.
Published: (2021-04-01)

Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
by: Klaus F. Bühler, et al.
Published: (2021-06-01)

Comparative pharmacology of a new recombinant FSH expressed by a human cell line
by: Wolfgang Koechling, et al.
Published: (2017-07-01)

A Novel Follitropin Analog Inhibits Follitropin Activity In Vitro
by: Naiel Azzam, et al.
Published: (2021-03-01)

New Human Follitropin Preparations: How Glycan Structural Differences May Affect Biochemical and Biological Function and Clinical Effect
by: James A. Dias, et al.
Published: (2021-03-01)

Human Recombinant FSH and Its Biosimilars: Clinical Efficacy, Safety, and Cost-effectiveness in Controlled Ovarian Stimulation for In Vitro Fertilization
by: Loredana Bergandi, et al.
Published: (2020-06-01)

Follitropin Delta as a State-of-the-Art Incorporated Companion for Assisted Reproductive Procedures: A Two Year Observational Study
by: Bogdan Doroftei, et al.
Published: (2021-04-01)

“In vitro” Effect of Different Follicle—Stimulating Hormone Preparations on Sertoli Cells: Toward a Personalized Treatment for Male Infertility
by: Iva Arato, et al.
Published: (2020-06-01)

Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007–2017)
by: Human Fatemi, et al.
Published: (2021-05-01)

Commentary: The Development of Gonadotropins for Clinical Use in the Treatment of Infertility
by: Fabiola Beligotti
Published: (2020-03-01)

Biosimilars in rheumatology and other fields of medicine
by: Marcin Milchert, et al.
Published: (2014-07-01)

Effectiveness Assessment of a Modified Preservation Solution Containing Thyrotropin or Follitropin Based on Biochemical Analysis in Perfundates and Homogenates of Isolated Porcine Kidneys after Static Cold Storage
by: Aneta Ostróżka-Cieślik, et al.
Published: (2021-08-01)

Authorisation of Non-Innovator Biotherapeutic (Biosimilar) Products in the USA
by: A. A. Soldatov, et al.
Published: (2019-03-01)

Biosimilars and Switching: What Is Your Perspective?
by: Sandoz
Published: (2017-08-01)

SERUM INHIBIN LEVELS IN NORMAL MEN AND MEN WITH IDIOPATHIC INFERTILITY
by: HIBI, HATSUKI, et al.
Published: (1995)

On the Regulatory Approval Pathway of Biosimilar Products
by: Jun Wang, et al.
Published: (2012-03-01)

Biosimilars: presumption of guilt
by: Marina Vladimirovna Shestakova, et al.
Published: (2011-12-01)

Isolated low follicle stimulating hormone (FSH) in infertile males – a preliminary report
by: Nader Salama, et al.
Published: (2013-09-01)

Managing infertility with the follitropin alfa prefilled pen injector – patient considerations
by: Bühler K
Published: (2015-06-01)

Effectiveness of corifollitropin alfa used for ovarian stimulation of poor responder patients
by: Selman H, et al.
Published: (2016-10-01)

The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA
by: Ioana Gherghescu, et al.
Published: (2021-12-01)

Sustainability of Biosimilars in Europe: A Delphi Panel Consensus with Systematic Literature Review
by: Arnold G. Vulto, et al.
Published: (2020-11-01)

Cannot write session to /tmp/vufind_sessions/sess_btegni04c9vnmt8cb4pti4tjdg